Immuron Ltd Files March 2024 Announcements on Form 6-K

Ticker: IMRN · Form: 6-K · Filed: Mar 14, 2024 · CIK: 1660046

Immuron LTD 6-K Filing Summary
FieldDetail
CompanyImmuron LTD (IMRN)
Form Type6-K
Filed DateMar 14, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: reporting, sec-filing, foreign-private-issuer

TL;DR

Immuron dropped its March announcements to the SEC, check the 6-K for details.

AI Summary

Immuron Limited filed a Form 6-K on March 14, 2024, reporting on four announcements made during March 2024. These announcements are being furnished to the SEC as part of their ongoing reporting obligations as a foreign private issuer. The filing does not contain specific financial figures or new material events beyond the reporting of these announcements.

Why It Matters

This filing provides an update on Immuron's recent communications to the market, which may contain information relevant to investors tracking the company's progress and disclosures.

Risk Assessment

Risk Level: low — This filing is a routine report of previously published announcements and does not introduce new material risks or significant financial changes.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

The purpose of this Form 6-K filing is to report four announcements published by Immuron Limited during the month of March 2024, as required for a foreign private issuer.

What specific announcements are being reported?

The filing states that Immuron Limited published four announcements, but the specific content of these announcements is not detailed within the provided text of the 6-K header.

When was this Form 6-K filed?

This Form 6-K was filed on March 14, 2024.

What is Immuron Limited's principal executive office address?

Immuron Limited's principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.

Does Immuron Limited file annual reports under Form 20-F?

Yes, Immuron Limited indicates it files annual reports under cover of Form 20-F.

Filing Stats: 355 words · 1 min read · ~1 pages · Grade level 16.8 · Accepted 2024-03-14 06:50:12

Filing Documents

From the Filing

OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of March 2024 Commission File Number: 001-38104 IMMURON LIMITED (Name of Registrant) Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes No If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- IMMURON LIMITED EXPLANATORY NOTE Immuron Limited (the “Company”) published four announcements (the “Public Notices”) to the Australian Securities Exchange on March 14, 2024 titled: - “Immuron CEO, Steven Lydeamore to present at Coffee Microcaps” “Application for quotation of securities – IMC” “Change of Director’s Interest Notice (DP)” “Notice under section 708A” A copy of the Public Notice is attached as an exhibit to this report on Form 6-K. This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. 1 EXHIBITS Exhibit Number Description 99.1 Immuron CEO, Steven Lydeamore to present at Coffee Microcaps 99.2 Application for quotation of securities – IMC 99.3 Change of Director’s Interest Notice (DP) 99.4 Notice under section 708A 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMURON LIMITED Date: March 14, 2024 By: /s/ Phillip Hains Phillip Hains Company Secretary 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing